← Back to Search

Neurostimulation Device

Epidural Spinal Cord Stimulation for Spinal Cord Injury (E-STAND Trial)

N/A
Recruiting
Led By David Darrow, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Intact segmental reflexes below the lesion of injury
Stable, motor-complete paraplegia
Must not have
Unhealed spinal fracture
Inability to withhold antiplatelet/anticoagulation agents perioperatively
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months: 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a way to improve epidural spinal cord stimulation for people with spinal cord injuries. The study will also look at how well autonomic function (such as blood pressure control) and other functions improve.

Who is the study for?
This trial is for adults over 22 with stable, motor-complete paraplegia due to spinal cord injury between C6 and T10. Participants must have had the injury for over a year, be medically stable, able to consent, and commit to all appointments. Excluded are those with certain health risks or conditions that complicate surgery or rehabilitation.
What is being tested?
The study tests optimizing epidural spinal cord stimulation settings to restore voluntary leg movement in people with paraplegia. It also looks at improvements in autonomic functions like blood pressure control related to spinal cord injuries.
What are the potential side effects?
While specific side effects aren't listed here, similar interventions may cause discomfort at the stimulation site, potential infection risk from surgery, and varying responses affecting blood pressure or reflexes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My reflexes below my injury site work.
Select...
I have stable paralysis affecting my lower limbs.
Select...
My spinal cord injury is between my neck and mid-back.
Select...
My spinal cord injury is classified as ASIA A or B.
Select...
I am 22 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a spinal fracture that has not yet healed.
Select...
I cannot stop taking my blood thinning medications for surgery.
Select...
I have a severe tightening of my skin or muscles.
Select...
I have frequent UTIs that antibiotics don't cure.
Select...
I don't have heart or lung problems that make spine surgery riskier.
Select...
I do not have severe nerve issues that prevent standing or a history of stroke or heart attack causing extreme blood pressure changes.
Select...
I can move my legs when asked during a muscle test.
Select...
I have pressure ulcers.
Select...
I have not had botulinum toxin injections in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months: 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
This trial's timeline: 3 weeks for screening, Varies for treatment, and months: 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Volitional Response Index Magnitude
Secondary study objectives
Cerebrovascular Assessment Change
Change in Visual Neurocognitive Assessment
Spinal cord stimulation for cardiovascular function
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Epidural Spinal Cord StimulationExperimental Treatment1 Intervention
Epidural Spinal Cord Stimulation

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,439 Previous Clinical Trials
1,621,858 Total Patients Enrolled
Minnesota Office of Higher EducationOTHER_GOV
4 Previous Clinical Trials
94 Total Patients Enrolled
Minneapolis Veterans Affairs Medical CenterFED
76 Previous Clinical Trials
354,685 Total Patients Enrolled
Hennepin County Medical Center, MinneapolisOTHER
21 Previous Clinical Trials
12,220 Total Patients Enrolled
Hennepin Healthcare Research InstituteOTHER
92 Previous Clinical Trials
77,093 Total Patients Enrolled
David Darrow, MDPrincipal InvestigatorUniversity of Minnesota
5 Previous Clinical Trials
125 Total Patients Enrolled

Media Library

Epidural Spinal Cord Stimulation (Neurostimulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT03026816 — N/A
~21 spots leftby Jan 2027